Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMS) Revenue
Annual & quarterly revenue history · segment & region breakdown
FMS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsFresenius Medical Care AG & Co. KGaA trailing twelve-month (TTM) revenue is $19.36B, an increase of 1.51% year-over-year from $19.63B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $19.63B | +$0.29B | +1.51% |
| 2024-12-31 | $19.34B | -$0.12B | -0.61% |
| 2023-12-31 | $19.45B | +$0.06B | +0.29% |
| 2022-12-31 | $19.40B | +$1.78B | +10.10% |
| 2021-12-31 | $17.62B | -$0.24B | -1.35% |
| 2020-12-31 | $17.86B | +$0.38B | +2.19% |
| 2019-12-31 | $17.48B | +$0.93B | +5.62% |
| 2018-12-31 | $16.55B | -$1.24B | -6.96% |
| 2017-12-31 | $17.78B | +$0.75B | +4.42% |
| 2016-12-31 | $17.03B | +$1.72B | +11.24% |
Compare revenue vs peers
Medical - Care FacilitiesCompare FMS revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Fresenius Medical Care AG & Co. KGaA receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Fresenius Medical Care AG & Co. KGaA reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Fresenius Medical Care AG & Co. KGaA's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
FMS revenue · 4 questionsFMS's trailing twelve-month (TTM) revenue is $19.36B. That is an increase of 1.51% year-over-year from $19.63B in FY2025.
▸ Source: FMP · Fresenius Medical Care AG & Co. KGaA SEC filings · GAAP · Fresenius Medical Care AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026